Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - imiquimod, quantity: 50 mg/g - cream - excipient ingredients: purified water; xanthan gum; benzyl alcohol; glycerol; polysorbate 60; propyl hydroxybenzoate; stearyl alcohol; white soft paraffin; methyl hydroxybenzoate; cetyl alcohol; isostearic acid; sorbitan monostearate - imiquad 5% cream is indicated for treatment of solar (actinic) keratosis on the face and the scalp (see precautions), and primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and the treatment of external genital and peri-anal warts (condyloma acuminata) in adults (see precautions).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - brimonidine tartrate, quantity: 1.5 mg/ml - eye drops, solution - excipient ingredients: magnesium chloride hexahydrate; boric acid; sodium chlorite; sodium chloride; carmellose sodium; borax; sodium hydroxide; purified water; hydrochloric acid; potassium chloride; calcium chloride dihydrate - alphagan p 1.5 eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan p 1.5 eye drops can be used in the treatment of glaucoma as either monotherapy or in combination with topical beta blockers.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dermocosmetica pty ltd - lidocaine, quantity: 40 mg/g - cream - excipient ingredients: trolamine; propylene glycol; purified water; dl-alpha-tocopheryl acetate; benzyl alcohol; hydrogenated lecithin; cholesterol; polysorbate 80; carbomer 940 - topical anaesthesia of intact skin prior to superficial skin procedures, including insertion of iv catheters and blood sampling.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - clobetasone butyrate, quantity: 0.5 mg/g - cream - excipient ingredients: citric acid monohydrate; chlorocresol; purified water; glycerol; cetostearyl alcohol; glyceryl monostearate; sodium citrate dihydrate; peg-100 stearate; stearic acid; carnauba wax; hard paraffin - short-term (up to 7 days) treatment of milder forms of eczema, dermatitis and other steroid responsive skin conditions.

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

meda pharmaceuticals ltd - imiquimod - cream - 50mg/1gram

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; lactic acid; purified water; isopropyl palmitate; glycerol; benzyl alcohol; sorbitol solution (70 per cent) (non-crystallising) - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - cream - excipient ingredients: chlorocresol; white soft paraffin; liquid paraffin; purified water; cetostearyl alcohol; cetomacrogol 1000 - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; phosphoric acid; monobasic sodium phosphate dihydrate; cetomacrogol 1000; sodium hydroxide; white soft paraffin - antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritis, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, statis dermatitis and psoriasis. indications as at 16 august 1999: antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - cream - excipient ingredients: butylated hydroxytoluene; purified water; hard fat; cetostearyl alcohol; glyceryl monostearate; glycerol; disodium edetate; peg-40 stearate; benzyl alcohol; decyl oleate; medium chain triglycerides - topical treatment of eczema and psoriasis.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.21 mg/g (equivalent: betamethasone, qty 1 mg/g) - cream - excipient ingredients: purified water; white soft paraffin; liquid paraffin; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.